HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC

NCT05834686 · clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing 302 Hospital